Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7949645rdf:typepubmed:Citationlld:pubmed
pubmed-article:7949645lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7949645lifeskim:mentionsumls-concept:C0036202lld:lifeskim
pubmed-article:7949645lifeskim:mentionsumls-concept:C0332174lld:lifeskim
pubmed-article:7949645lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:7949645pubmed:issue7lld:pubmed
pubmed-article:7949645pubmed:dateCreated1994-12-15lld:pubmed
pubmed-article:7949645pubmed:abstractTextLow-dose methotrexate therapy has been used to treat a variety of chronic inflammatory diseases; a few studies have discussed the efficacy of this therapy for sarcoidosis. We present a patient with symptomatic sarcoidosis who was successfully treated with low-dose methotrexate after being refractory to steroids. This patient showed significant clinical improvement without development of any severe side effects. These findings suggest that low-dose methotrexate therapy may be a useful alternative treatment for sarcoidosis.lld:pubmed
pubmed-article:7949645pubmed:languageenglld:pubmed
pubmed-article:7949645pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7949645pubmed:citationSubsetIMlld:pubmed
pubmed-article:7949645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7949645pubmed:statusMEDLINElld:pubmed
pubmed-article:7949645pubmed:monthJullld:pubmed
pubmed-article:7949645pubmed:issn0918-2918lld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:YagiTTlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:SatoAAlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:ShiraiMMlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:TamuraRRlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:SudaTTlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:HayakawaHHlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:YoshitomeEElld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:ToyoshimaMMlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:ImokawaSSlld:pubmed
pubmed-article:7949645pubmed:authorpubmed-author:SuganumaHHlld:pubmed
pubmed-article:7949645pubmed:issnTypePrintlld:pubmed
pubmed-article:7949645pubmed:volume33lld:pubmed
pubmed-article:7949645pubmed:ownerNLMlld:pubmed
pubmed-article:7949645pubmed:authorsCompleteNlld:pubmed
pubmed-article:7949645pubmed:pagination437-40lld:pubmed
pubmed-article:7949645pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7949645pubmed:meshHeadingpubmed-meshheading:7949645-...lld:pubmed
pubmed-article:7949645pubmed:meshHeadingpubmed-meshheading:7949645-...lld:pubmed
pubmed-article:7949645pubmed:meshHeadingpubmed-meshheading:7949645-...lld:pubmed
pubmed-article:7949645pubmed:meshHeadingpubmed-meshheading:7949645-...lld:pubmed
pubmed-article:7949645pubmed:meshHeadingpubmed-meshheading:7949645-...lld:pubmed
pubmed-article:7949645pubmed:year1994lld:pubmed
pubmed-article:7949645pubmed:articleTitleWeekly low-dose methotrexate therapy for sarcoidosis.lld:pubmed
pubmed-article:7949645pubmed:affiliationDepartment of Internal Medicine, Hamamatsu University School of Medicine.lld:pubmed
pubmed-article:7949645pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7949645pubmed:publicationTypeCase Reportslld:pubmed